Join to view full profile
106 Boston AveSte 105Altamonte Springs, FL 32701
Phone+1 407-553-7710
Fax+1 866-445-1446
Dr. Ambinder is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1978 - 1980- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1976 - 1978
- Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1975 - 1976
Columbia University Vagelos College of Physicians and SurgeonsClass of 1975
Certifications & Licensure
FL State Medical License 1979 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Publications & Presentations
PubMed
- 4 citationsPhase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.David C. Smith, Duncan I. Jodrell, Merrill J. Egorin, Roy M. Ambinder, Eleanor G. Zuhowski
Cancer Chemotherapy and Pharmacology. 1993-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
